Officer exercised or converted 50K BSX derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Nov 3, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Nov 4, 2025
OfficerOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001225208-25-008911
Filed / recordedNov 4, 2025, 9:15 PM UTCAdded to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly IssuerBOSTON SCIENTIFIC CORP Reporting personJoseph Michael Fitzgerald Officer titleEVP & Group Pres, Cardiology TableNon-derivative (Table I) Transaction dateNov 3, 2025 Acquired / disposedAcquired (A) Shares owned after228,342 Footnotes from the filing
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 27, 2025.
Around the same time
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.